Skip to main content

Day: October 12, 2023

WTW to Announce Third Quarter Earnings on October 26, 2023

LONDON, Oct. 12, 2023 (GLOBE NEWSWIRE) — WTW (Willis Towers Watson, NASDAQ: WTW), a leading global advisory, broking and solutions company, will announce its financial results for the third quarter on Thursday, October 26, 2023 before the market opens. The company will host a conference call to discuss its financial results at 9:00 a.m. Eastern Time on October 26, 2023. A live broadcast of the conference call will be available on WTW’s website here. The conference call will include a question-and-answer session. To participate in the question-and-answer session, please register here. An online replay will be available at www.wtwco.com shortly after the call concludes. About WTWAt WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in the areas of people, risk and capital. Leveraging the global view and local expertise...

Continue reading

Stellantis to Announce Third Quarter 2023 Shipments and Revenues on October 31

 Stellantis to Announce Third Quarter 2023 Shipments and Revenues on October 31 AMSTERDAM, October 12, 2023 – Stellantis N.V. announced today that its Third Quarter 2023 Shipments and Revenues will be released on Tuesday, October 31, 2023. A live audio webcast and conference call of the Third Quarter 2023 Shipments and Revenues will begin at 1:00 p.m. CET / 8:00 a.m. EDT on Tuesday, October 31, 2023. The related press release and presentation material are expected to be posted under the Investors section of the Stellantis corporate website at www.stellantis.com at approximately 8:00 a.m. CET / 3:00 a.m. EDT on Tuesday, October 31, 2023. Details for accessing this presentation are available under the Investors section of the Stellantis corporate website at www.stellantis.com. For those unable to participate in the live session, a recorded...

Continue reading

Aleafia Health Announces Successful Bids in Sale and Investment Solicitation Process

TORONTO, Oct. 12, 2023 (GLOBE NEWSWIRE) — Aleafia Health Inc. (“Aleafia” or the “Corporation”) announces that Red White & Bloom Brands Inc. (“RWB”) has been selected as the successful bidder pursuant to the Court-approved sale and investment solicitation process (the “SISP”) in connection with the previously announced proceedings of Aleafia and certain of its subsidiaries under the Companies’ Creditors Arrangement Act (the “CCAA”). On August 22, 2023, the Ontario Superior Court of Justice (Commercial List) (the “Court”) approved, among other matters, the terms of a SISP which included a stalking horse asset purchase and share subscription agreement (the “Stalking Horse Agreement”) pursuant to which RWB would acquire certain assets from Aleafia and subscribe for shares of certain subsidiaries of Aleafia if RWB were to become...

Continue reading

Yoshitsu Co., Ltd. Announces the Grand Opening of its REIWATAKIYA Flagship Store in London

Tokyo, Japan, Oct. 12, 2023 (GLOBE NEWSWIRE) — Yoshitsu Co., Ltd. (“Yoshitsu” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, as well as sundry products and other products in Japan, is thrilled to announce the grand opening of its REIWATAKIYA flagship store located at 47 South Molton Street, London W1K 5RY (the “Store”), near Bond Street in London. The Store is set to open for business at the end of October 2023. Spanning 144 square meters, the Store is expected to showcase a selection from the Company’s catalog of over 8,000 products. Offering products from daily essentials to high-end luxuries, the location near Bond Street is anticipated to enable the Company to provide its customers a shopping experience in the heart of London’s premium retail...

Continue reading

ParaZero Technologies and Maris-Tech Expand their Collaboration into the Defense Market for Drones

The joint solution will integrate safety technology and predictive maintenance into a unified platform, leveraging Maris-Tech’s artificial intelligence and video analytics capabilities Tel Aviv, Israel, Oct. 12, 2023 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (“ParaZero”), an aerospace company focused on drone safety systems for commercial drones and urban air mobility aircraft, and Maris-Tech Ltd. (Nasdaq: MTEK) (“Maris-Tech”), a B2B provider of edge artificial intelligence (“AI”) accelerated video solutions for edge platforms, including drones, today announced an expansion of their collaboration. ParaZero and Maris-Tech entered into a letter of intent pursuant to which the companies will collaborate to develop a unified product, integrating safety technology and predictive maintenance....

Continue reading

Total voting rights (Correction)

Thames Ventures VCT 1 plcLEI: 213800R88MRC4Y3OIW86Correction – Total Voting Rights12 October 2023 Please see below a correction to the total voting rights and number of shares in issue published in an announcement on 11th October 2023. In conformity with the Disclosure and Transparency Rule 5.6.1, Thames Ventures VCT 1 plc announces that the Company’s capital and voting rights, as at 30 September 2023, are summarised as follows:  Shares in issue Voting rights per share Voting rightsOrdinary Shares of 1p each 176,968,887 1 176,968,887Total Voting Rights     176,968,887The Company does not hold any shares in treasury. The above takes account of any shares that have recently been bought back for cancellation, even if such transactions have not yet settled. The above figures may be used by Shareholders as the denominator...

Continue reading

Windtree to Present at the ThinkEquity Conference on October 19th in New York City

WARRINGTON, Pa., Oct. 12, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced that Craig Fraser, President and Chief Executive Officer, will be presenting at the upcoming ThinkEquity Conference on Thursday, October 19, 2023 at 4:30pm ET. Windtree management will also be hosting 1×1 meetings with investors at the event. The presentation will provide clinical development and business updates, including the Company’s progress on its lead product candidate istaroxime in cardiogenic shock. Click here to register and attend the event: Click here. About IstaroximeIstaroxime is a first-in-class dual mechanism therapy designed to improve both systolic and diastolic cardiac...

Continue reading

Q3-2023: 22% revenue growth YTD compared to 2022 and first month of net profit

Company Announcement no. 131 – 2023Copenhagen, October 12th, 2023 Q3-2023: 22% revenue growth YTD compared to 2022 and first month of net profit During Q3-2023, GreenMobility generated a growth in revenue of 10% compared to Q3 last year and YTD the revenue has grown by 22%. The quarter has to some extent been impacted by summer travels in July and August and continued in-phasing in of cars in some markets. Overall, all markets have seen revenue growth. Q3 ended with September becoming the first ever month with positive net profit on Group level in the level of DKK 0.5 million, as announced in company announcement no 130 on 9 October 2023. On YTD 2023, the net result has been improved by 40% compared to YTD 2022. This marks a significant step towards the company’s strategic plan of being profitable in 2024. The strategic focus includes...

Continue reading

RoodMicrotec and CERN intensify their cooperation in ASIC testing

Deventer, October 12, 2023 – RoodMicrotec N.V., a leading independent company for semiconductors supply and quality services, and CERN, the European Laboratory for Particle Physics, are expanding their collaboration with the Compact Muon Solenoid (CMS) Outer Tracker ASICs project. The long-standing partners are thus jointly facing another large and significant project. The ASICs tested for the CMS will enable the collection of essential data during experiments in the Large Hadron Collider (LHC). The LHC is purpose-built to help scientists in addressing fundamental questions within the field of particle physics. As part of the planned 2026 upgrade to the CMS detector, CERN will again use RoodMicrotec’s expertise and testing services. RoodMicrotec will test and deliver over 1,000 12″ silicon wafers. The three ASIC modules on...

Continue reading

Chr. Hansen Holding A/S Interim Report Q4 2022/23

October 12, 2023 – Company announcement no. 9 Strong performance for the quarter despite a challenging environment  Statement by CEO Mauricio Graber: “Supported by a strong Q4 performance, Chr. Hansen delivered a solid result for the first twelve months of the extended financial year 2022/23 at the upper end of our guidance with 11% organic revenue growth and an EBIT margin b.s.i. of 26.9%. Throughout the year, we have demonstrated the attractiveness of the markets we serve and the resilience of our business model, supported by a robust and agile organization adapting to changing customer requirements in a challenging environment. Together with Novozymes, we continue the regulatory approval process in relation to the proposed merger with closing expected in the fourth quarter of the calendar year 2023 or the first quarter of the calendar...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.